Published: 2016-12-29

Lower diastolic blood pressure in healthy subjects with vitamin K deficiency: a preliminary cross-sectional study

Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poznan, Poland
menaquinone hypertension K2 arterial stiffness osteocalcin

Abstract

Introduction. There is a growing body of evidence for the role of vitamin K in cardiovascular health. As a cofactor of carboxylation of the matrix Gla protein it prevents arterial calcification. However, the data on the relationship between vitamin K status and the blood pressure are scarce, and particularly so in persons without the burden of cardiovascular risk factors.
Material and Methods. We performed a pilot cross-sectional study, in which we hypothesized that vitamin K deficiency is associated with a higher blood pressure in young, healthy people. The concentration of protein induced by vitamin K absence-II (PIVKA-II) larger than 2 ng/mL was chosen as a proxy for vitamin K deficiency; it was assessed in serum using ELISA. Blood pressure was measured using a validated, automated oscillometric monitor in triplicate.
Results. Twenty-three healthy subjects were enrolled (16 female; mean age 21.3 ± 1.6 years; body mass index 20.6 ± 2.4 kg/m2). The diastolic blood pressure (DBP) was lower in vitamin K-deficient subjects (58 ± 9 vs. 67 ± 5 mmHg, p = 0.01). The mean arterial blood pressure also differed (75 ± 9 vs. 83 ± 6, p = 0.02). PIVKA-II levels correlated with DBP only (Pearson’s R = -0.41, p < 0.05; Spearman’s ? ns.). Stepwise regression identified PIVKA-II concentrations as the only independent parameter associated with DBP (adjusted R2 = 13.1%; PIVKA-II: ß = -0.41; 95%CI -1.87-(-0.00098), t = -2.08, p < 0.05).
Conclusions. The relationship between vitamin K deficiency and low DBP in young adults should be investigated further.

Downloads

Download data is not yet available.

References

  1. Pivin E, Ponte B, Pruijm M, Ackermann D, Guessous I, Ehret G et al. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study. Hypertens Dallas Tex. 2015;66:85–92.
  2. Cundiff DK, Agutter PS. Cardiovascular Disease Death Before Age 65 in 168 Countries Correlated Statistically with Biometrics, Socioeconomic Status, Tobacco, Gender, Exercise, Macronutrients, and Vitamin K. Cureus. 2016;8:e748.
  3. Madry E, Nowak J, Wykretowicz A, Wenska-Chyzy E, Miskiewicz-Chotnicka A, Walkowiak J. Predicting the risk of atherosclerosis in patients with cystic fibrosis – rationale and design of a prospective cohort study. J Med Sci. 2015;84:126–128.
  4. El Assaad MA, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron M5-I and the Omron 705IT. Blood Press Monit. 2003;8:127–133.
  5. Omboni S, Riva I, Giglio A, Caldara G, Groppelli A, Parati G. Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Press Monit. 2007;12:233–242.
  6. Lim MA, Shafique S, See SY, Khan FN, Parikh CR, Peixoto AJ. Effects of warfarin on blood pressure in men with diabetes and hypertension--a longitudinal study. J Clin Hypertens Greenwich Conn. 2007;9:256–258.
  7. Kallistratos MS, Manolis AJ, Mancia G. Blood pressure. The forgotten factor in previous and recent studies regarding anticoagulation in atrial fibrillation. Int J Cardiol. 2013;168:4434–4435.
  8. Essalihi R, Dao HH, Yamaguchi N, Moreau P. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens. 2003;16:103–110.
  9. Ware KM, Vance JC, Muni N, Hebert LA, Satoskar AA, Nadasdy G et al. Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants? Am J Hypertens. 2015;28:182–189.
  10. McCabe KM, Booth SL, Fu X, Shobeiri N, Pang JJ, Adams MA et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int. 2013;83:835–844.
  11. Rennenberg RJMW, de Leeuw PW, Kessels AGH, Schurgers LJ, Vermeer C, van Engelshoven JMA et al. Calcium scores and matrix Gla protein levels: association with vitamin K status. Eur J Clin Invest. 2010;40:344–349.
  12. Knapen MHJ, Braam LAJLM, Drummen NE, Bekers O, Hoeks APG, Vermeer C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb Haemost. 2015;113:1135–1144.
  13. Vossen LM, Schurgers LJ, van Varik BJ, Kietselaer BLJH, Vermeer C, Meeder JG et al. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial). Nutrients. 2015;7:8905–8915.
  14. Fulton RL, McMurdo MET, Hill A, Abboud RJ, Arnold GP, Struthers AD et al. Effect of Vitamin K on Vascular Health and Physical Function in Older People with Vascular Disease--A Randomised Controlled Trial. J Nutr Health Aging. 2016;20:325–333.
  15. Dalmeijer GW, van der Schouw YT, Magdeleyns E, Ahmed N, Vermeer C, Beulens JWJ. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein. Atherosclerosis. 2012;225:397–402.
  16. Koitaya N, Ezaki J, Nishimuta M, Yamauchi J, Hashizume E, Morishita K et al. Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women. J Nutr Sci Vitaminol (Tokyo). 2009;55:15–21.
  17. Karl JP, Fu X, Wang X, Zhao Y, Shen J, Zhang C et al. Fecal menaquinone profiles of overweight adults are associated with gut microbiota composition during a gut microbiota-targeted dietary intervention. Am J Clin Nutr. 2015;102:84–93.
  18. Pan Y, Jackson RT. Dietary phylloquinone intakes and metabolic syndrome in US young adults. J Am Coll Nutr. 2009;28:369–379.
  19. Van Ballegooijen A, Van Schoor N, Brouwer I, Visser M, Beulens J. OS 06–09 the synergistic association between vitamin D and vitamin K with incident hypertension. J Hypertens. 2016;34(Suppl 1):e64.
  20. Pivin E, Pruijm M, Ackermann D, Guessous I, Ehret G, Pechere-Bertschi A et al. 1D.03: Inactive matrix GLA protein is associated with renal resistive index in a population-based study. J Hypertens. 2015;33(Suppl 1):e15.
  21. Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013;14:365–376.

How to Cite

1.
Nowak JK, Wykrętowicz A, Krzyżanowska P, Górna A, Tobolski J, Mądry E, Walkowiak J. Lower diastolic blood pressure in healthy subjects with vitamin K deficiency: a preliminary cross-sectional study. JMS [Internet]. 2016Dec.29 [cited 2020Aug.8];85(4):276. Available from: https://jms.ump.edu.pl/index.php/JMS/article/view/181